| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Wapnick Pamela is a Chief Financial Officer at Metagenomi Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $250K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | MGX Metagenomi Therapeutics, Inc. | Chief Financial Officer | Sell | 2,884 | $1.30 | $3,746.32 | -1.4% | - | - | |
| Dec 5, 2025 | MGX Metagenomi, Inc. | Chief Financial Officer | Sell | 1,576 | $1.77 | $2,792.51 | -0.8% | -9.6% | - | |
| Sep 5, 2025 | MGX Metagenomi, Inc. | Chief Financial Officer | Sell | 1,576 | $1.81 | $2,852.56 | -2.2% | -6.3% | - | |
| Jun 6, 2025 | MGX Metagenomi, Inc. | Chief Financial Officer | Sell | 1,576 | $1.75 | $2,758.00 | -2.1% | +2.9% | -26.0% | |
| Mar 5, 2025 | MGX Metagenomi, Inc. | Chief Financial Officer | Sell | 1,808 | $1.87 | $3,389.64 | -2.9% | -9.2% | -17.4% | |
| Dec 5, 2024 | MGX Metagenomi, Inc. | Chief Financial Officer | Sell | 1,559 | $1.86 | $2,899.74 | -2.5% | +5.4% | -3.8% | |
| Sep 5, 2024 | MGX Metagenomi, Inc. | Chief Financial Officer | Sell | 6,265 | $2.88 | $18,043.20 | -9.0% | -35.9% | -34.1% |